Here's the live share price of Ajanta Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Ajanta Pharma has gained 18.07% CAGR. Over the past year, the corresponding return has been -18.88%.
Ajanta Pharma’s current P/E of 32.38x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Ajanta Pharma | -1.13 | -4.71 | -13.73 | -13.46 | -18.88 | 24.76 | 18.07 |
| Sun Pharmaceutical Industries | 1.22 | 4.47 | 0.44 | -5.81 | -8.08 | 19.88 | 29.07 |
| Divi's Laboratories | 0 | 10.61 | -0.01 | 6.48 | 15.43 | 22.37 | 16.83 |
| Cipla | 0.38 | 2.98 | 6.49 | 2.09 | 6.16 | 11.37 | 16.28 |
| Torrent Pharmaceuticals | -0.05 | -1.05 | 1.74 | 7.60 | 7.83 | 31.62 | 21.93 |
| Dr. Reddy's Laboratories | 2.31 | -1.10 | 1.59 | 6.95 | -2.39 | 13.65 | 5.23 |
| Zydus Lifesciences | 1.86 | -2.85 | 3.56 | 14.30 | 0.05 | 34.52 | 19.18 |
| Mankind Pharma | -2.22 | -4.19 | -6.36 | -6.90 | -3.34 | 19.39 | 11.22 |
| Lupin | -0.25 | -2.88 | -0.49 | -8.12 | -9.21 | 41.67 | 14.96 |
| Alkem Laboratories | -0.72 | -0.62 | 10.88 | 6.17 | -6.95 | 21.39 | 16.37 |
| Abbott India | 0.31 | -0.84 | -13.67 | -0.43 | 4.48 | 17.65 | 13.94 |
| Aurobindo Pharma | -1.48 | -0.58 | -2.53 | -13.71 | -24.73 | 27.44 | 6.70 |
| Glenmark Pharmaceuticals | -2.30 | -9.88 | -15.20 | 27.90 | 8.68 | 65.89 | 30.65 |
| Laurus Labs | 2.83 | 1.78 | 10.70 | 42.97 | 107.46 | 24.47 | 23.97 |
| Biocon | 0.87 | 0.08 | -9.66 | 10.03 | 11.45 | 9.95 | -2.25 |
| GlaxoSmithKline Pharmaceuticals | 0.43 | 0.19 | -12.87 | -5.61 | 5.14 | 26.09 | 13.05 |
| Anthem Biosciences | -4.95 | -12.36 | -4.93 | -1.44 | -1.44 | -0.48 | -0.29 |
| Cohance Lifesciences | -1.46 | -2.12 | -15.27 | -27.13 | -30.50 | 28.80 | 21.50 |
| Ipca Laboratories | -1.33 | -6.03 | -17.67 | -12.24 | -19.71 | 12.12 | 3.59 |
| Gland Pharma | 0.48 | -1.58 | -3.59 | 32.72 | 18.53 | -3.87 | 1.33 |
Over the last one year, Ajanta Pharma has declined 18.88% compared to peers like Sun Pharmaceutical Industries (-8.08%), Divi's Laboratories (15.43%), Cipla (6.16%). From a 5 year perspective, Ajanta Pharma has outperformed peers relative to Sun Pharmaceutical Industries (29.07%) and Divi's Laboratories (16.83%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,442.21 | 2,432.99 |
| 10 | 2,428.59 | 2,434.35 |
| 20 | 2,441.51 | 2,450.56 |
| 50 | 2,531.67 | 2,508.88 |
| 100 | 2,586.18 | 2,561.41 |
| 200 | 2,623.72 | 2,603.28 |
In the latest quarter, Ajanta Pharma remained same as its previous close in promoter holding, while DII stake increased to 17.90%, FII holding fell to 8.53%, and public shareholding moved down to 7.32% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 16,74,471 | 0.61 | 402.93 | |
| 14,15,187 | 1.35 | 340.54 | |
| 12,19,302 | 1.68 | 293.4 | |
| 9,59,323 | 2.85 | 230.84 | |
| 9,28,520 | 0.88 | 223.43 | |
| 8,97,224 | 0.8 | 215.9 | |
| 8,40,000 | 1.73 | 202.13 | |
| 8,07,460 | 0.41 | 194.3 | |
| 4,24,692 | 0.9 | 102.19 | |
| 3,96,834 | 0.34 | 95.49 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Oct 24, 2025, 3:32 PM IST | Ajanta Pharma Lt - Corporate Action- Fixation Of Record Date For 1St Interim Dividend |
| Oct 24, 2025, 3:27 PM IST | Ajanta Pharma Lt - Corporate Action-Board to consider Dividend |
| Oct 24, 2025, 3:19 PM IST | Ajanta Pharma Lt - Update on board meeting |
| Oct 08, 2025, 10:17 PM IST | Ajanta Pharma Lt - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Oct 08, 2025, 5:23 PM IST | Ajanta Pharma Lt - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
Ajanta Pharma Ltd. is a Public Limited Listed company incorporated on 31/12/1979 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1979PLC022059 and registration number is 022059. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 4322.04 Cr. and Equity Capital is Rs. 25.07 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Ajanta Pharma is ₹2,411.00 as on Oct 24, 2025.
The Ajanta Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Ajanta Pharma is ₹30,116.31 Cr as on Oct 24, 2025.
Today’s highest and lowest price of Ajanta Pharma are ₹2,433.85 and ₹2,389.00.
The 52-week high/low is the highest and lowest price at which Ajanta Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Ajanta Pharma is ₹3,177.20 and 52-week low of Ajanta Pharma is ₹2,022.05 as on Oct 24, 2025.
The Ajanta Pharma has shown returns of -0.22% over the past day, -4.71% for the past month, -13.73% over 3 months, -18.88% over 1 year, 24.76% across 3 years, and 18.07% over 5 years.
P/E ratio of and PB ratio of Ajanta Pharma are 32.38 and 8.19 on Oct 24, 2025. While the company gives a dividend yield of 1.16 per annum.